Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001642 · ClinicalTrials.gov registry record
Positional Cloning of the Gene(s) Responsible for Alagille Syndrome
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 225
- Enrollment target
NCT00001642 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 225 participants.
The verdict
NCT00001642 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 225 participants
- Enrollment target
Study Summary
The goal of the project is to identify and clone the gene(s) responsible for the Alagille Syndrome (AGS) by a positional cloning approach. The first step towards this goal is to define the smallest genomic candidate region for AGS at 20p12 and to begin to identify genes within this region which are, by definition, candidate genes for the disease. In a collaborative effort with clinician-investigators studying the Alagille syndrome, metaphase chromosomes and genomic DNA from affected individuals will be studied for subchromosomal deletions and for mutations in the candidate genes. Characterization of genes involved in Alagille syndrome could provide important insight into the pathophysiology of the disease, the development of normal liver and treatment of this disease. Recently, we and others found that mutations in Jagged1, a Notch1 receptor are responsible for Alagille Syndrome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 1997-05 |
| Est. Completion | 2000-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001642
The ClinicalTrials.gov registry entry for NCT00001642 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001642 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001642 about?
NCT00001642 is a clinical study titled "Positional Cloning of the Gene(s) Responsible for Alagille Syndrome". The goal of the project is to identify and clone the gene(s) responsible for the Alagille Syndrome (AGS) by a positional cloning approach. The first step towards this goal is to define the smallest genomic candidate region for AGS at 20p12 and to begin to identify genes within this region which are,...
What is the current status of trial NCT00001642?
This trial is currently completed. The enrollment target is 225 participants. The study started on 1997-05. Estimated completion is 2000-03.
Who is sponsoring clinical trial NCT00001642?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.